Skip to main content
. 2009 Oct 28;101(2):530–535. doi: 10.1111/j.1349-7006.2009.01418.x

Figure 3.

Figure 3

 Patients without risk genotypes (GSTP1‐105 Ile/Ile, ERCC1‐118 C/T or T/T, and XPD‐751 Lys/Gln) have a significantly longer progression‐free as well as overall survival time after treatment with FOLFOX‐4. (a) Progression‐free survival curves of 166 patients with or without any risk genotype plotted by Kaplan–Meier method (P < 0.01, log‐rank test). (b) A similar method has been used to plot overall survival curves of patients with or without any risk genotype (P < 0.01).